Literature DB >> 31102833

Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJSi001-A.

Jing Sun1, Xiaoya Zhang2, Qijie Cong2, Cong Wang3, Dong Chen2, Yincheng Wang2, Xiaowen Wang2, Zhenghui Yi4, Shengying Qin5.   

Abstract

Schizophrenia is considered one of the most serious mental disorders nowadays. Approximately 30-60% of people with schizophrenia do not present adequate response to drug treatment and persist with symptoms of the disease; they are known as refractory schizophrenic people. We generated induced pluripotent stem cells (iPSCs) from a refractory schizophrenia patient by electroporation of peripheral blood mononuclear cells (PBMC) with episomal plasmids encoding OCT 4, SOX 2, NANOG, LIN 28, KLF 4 and LMYC. The resulting iPSCs had normal karyotype, were free of genomically integrated episomal plasmids, expressed pluripotency markers, and could differentiate into the three germ layers in vivo.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31102833     DOI: 10.1016/j.scr.2019.101460

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  1 in total

1.  Treatment-Resistant Schizophrenia.

Authors:  Peter F Buckley
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.